Safety Signal Program
Detect risks early with proactive signal management
Enhance patient safety with QbD Group's Safety Signal Program. Detect risks early, ensure compliance, and build trust with proactive safety solutions through systematic signal detection and management.
What is a Safety Signal Program?
Signal detection and management is the systematic process of identifying, evaluating, and acting upon new or changing safety information associated with medicinal products. A robust signal program is essential for maintaining an accurate benefit-risk profile and protecting patient safety throughout the product lifecycle.
Our signal management services include:
- Signal detection: Systematic review of safety data sources — including ICSRs, literature, clinical trials, and post-marketing surveillance — to identify potential new risks.
- Signal validation: Rigorous evaluation of detected signals to determine whether they represent genuine safety concerns requiring further action.
- Signal evaluation and assessment: In-depth analysis of validated signals including causality assessment, frequency analysis, and clinical significance evaluation.
- Signal management and tracking: End-to-end tracking of signals from detection through to resolution, including regulatory communication and risk minimization recommendations.
- PRAC and regulatory reporting: Preparing and submitting signal-related communications to the EMA Pharmacovigilance Risk Assessment Committee (PRAC) and other regulatory authorities.
- Signal management procedures: Developing and implementing SOPs and workflows for your organization's signal management activities.
Why is Signal Detection & Management essential?
Early risk identification
Proactive signal detection enables early identification of emerging safety concerns before they escalate.
Regulatory compliance
Signal management is mandated by GVP Module IX — robust processes are essential for EMA and global regulatory compliance.
Patient protection
Timely signal evaluation and risk mitigation measures directly contribute to patient safety.
Data-driven decisions
Structured signal assessment provides the evidence base for benefit-risk evaluations and regulatory actions.
Product lifecycle management
Continuous signal monitoring supports ongoing benefit-risk assessment throughout the product's market life.
How can we help?
QbD Group's Safety Signal Program provides comprehensive signal detection and management services:
Systematic signal detection
Regular screening of multiple data sources to identify potential new safety signals.
Signal validation and prioritization
Rigorous evaluation to confirm genuine signals and prioritize them based on clinical significance.
In-depth signal assessment
Comprehensive analysis including causality, frequency, and benefit-risk evaluation.
Regulatory communication
Preparing PRAC submissions and regulatory authority communications related to identified signals.
SOP development
Creating and implementing signal management procedures tailored to your organization.
End-to-end signal tracking
Complete lifecycle management from detection through resolution and documentation.
Why QbD Group
Your trusted partner
Choosing QbD Group for signal detection and management ensures:
Expert signal management team
experienced pharmacovigilance professionals with deep expertise in GVP Module IX requirements.
Comprehensive approach
systematic signal detection across all relevant data sources including ICSRs, literature, and clinical data.
Regulatory expertise
proven experience with PRAC communications and global regulatory authority interactions.
Structured processes
robust SOPs and workflows that ensure consistent and compliant signal management.
Actionable insights
translating signal data into clear recommendations for risk mitigation and benefit-risk management.
Let's talk Pharmacovigilance
From QPPV services to signal management, our safety experts are ready to support your pharmacovigilance needs.